MedPath

Furosemide

FUROSEMIDE TABLETS, USP20 mg, 40 mg and 80 mg

Approved
Approval ID

09ea0b52-dd3d-4490-999a-b0b3679d5b24

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 2, 2010

Manufacturers
FDA

State of Florida DOH Central Pharmacy

DUNS: 829348114

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

FUROSEMIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53808-0367
Application NumberNDA018487
Product Classification
M
Marketing Category
C73594
G
Generic Name
FUROSEMIDE
Product Specifications
Route of AdministrationORAL
Effective DateJune 2, 2010
FDA Product Classification

INGREDIENTS (6)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
FUROSEMIDEActive
Quantity: 20 mg in 1 1
Code: 7LXU5N7ZO5
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Furosemide - FDA Drug Approval Details